Idexx Laboratories (IDXX) Income from Continuing Operations (2009 - 2026)

Idexx Laboratories (IDXX) has reported Income from Continuing Operations for 18 consecutive years, with 278446000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Income from Continuing Operations rose 14.74% year-over-year to 278446000.0; the TTM figure through Mar 2026 stood at 1095233000.0 (up 22.38% YoY), while the FY2025 annual figure was 1059464000.0, up 19.33% from the prior year.
• Income from Continuing Operations came in at 278446000.0 for Q1 2026 at Idexx Laboratories, up from 248188000.0 in the prior quarter.
• The five-year high for Income from Continuing Operations was 293989000.0 in Q2 2025, with the low at 131979000.0 in Q2 2022.
• Average Income from Continuing Operations over 5 years is 220582823.53, with a median of 216149000.0 recorded in 2024.
• Across the five-year window, Income from Continuing Operations sank 34.86% in 2022 and soared 69.9% in 2023, its largest moves.
• Year by year, Income from Continuing Operations stood at 172207000.0 in 2022, then rose by 12.96% to 194521000.0 in 2023, then advanced by 11.12% to 216149000.0 in 2024, then rose by 14.82% to 248188000.0 in 2025, then grew by 12.19% to 278446000.0 in 2026.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 278446000.0, 248188000.0, and 274610000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.